MIFH
IDXX icon

Migdal Insurance & Financial Holdings’s Idexx Laboratories IDXX Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-76
Closed -$51K – 396
2025
Q4 		$51K Sell
76
-17
-18% -$11.6K ﹤0.01% 276
2025
Q3 		$59K Buy
+93
New +$56.4K ﹤0.01% 261
2025
Q2 		– Sell
-84
Closed -$35K – 387
2025
Q1 		$35K Buy
84
+30
+56% +$13K ﹤0.01% 311
2024
Q4 		$22K Buy
54
+19
+54% +$8.33K ﹤0.01% 284
2024
Q3 		$18K Buy
35
+22
+169% +$10.7K ﹤0.01% 305
2024
Q2 		$6K Buy
+13
New +$6.53K ﹤0.01% 461
2021
Q4 		– Sell
-68
Closed -$42K – 713
2021
Q3 		$42K Buy
+68
New +$45.7K ﹤0.01% 470
2020
Q2 		– Sell
-261
Closed -$63K – 718
2020
Q1 		$63K Buy
+261
New +$68.1K ﹤0.01% 450
2018
Q4 		– Sell
-618
Closed -$154K – 753
2018
Q3 		$154K Buy
618
+365
+144% +$88.6K ﹤0.01% 551
2018
Q2 		$55K Buy
253
+245
+3,063% +$50.5K ﹤0.01% 632
2018
Q1 		$2K Buy
+8
New +$1.48K ﹤0.01% 612

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Migdal Insurance & Financial Holdings's IDXX Position: Q1 2026 in Review

Migdal Insurance & Financial Holdings sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 76 shares — an estimated $51K sold.

Migdal Insurance & Financial Holdings first reported a position in IDXX in Q1 2018 and held it in 11 quarters. The position peaked at $154K in Q3 2018. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Migdal Insurance & Financial Holdings reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 76 Idexx Laboratories shares in Q1 2026, an estimated $51K.
  • Migdal Insurance & Financial Holdings first reported a position in Idexx Laboratories in Q1 2018 and held it in 11 quarters.
  • Migdal Insurance & Financial Holdings's Idexx Laboratories position peaked at $154K in Q3 2018.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2026, filed 14 May 2026.